Return to homepagePandemic Pact

Covid-19: SARS-CoV-2 genomic surveillance

  • Funded by Federal Office of Public Health (FOPH)
  • Total publications:0 publications

Grant number: 52089

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2023

  • Known Financial Commitments (USD)

    $1,949,711.4

  • Funder

    Federal Office of Public Health (FOPH)

  • Principal Investigator

    Abteilung Übertragbare Krankheiten Sekretariat der

  • Research Location

    Switzerland

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Epidemiological studies

  • Research Subcategory

    Disease surveillance & mapping

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The subsidy from this contract enables the continuation of the national genomic surveillance program for the SARS-CoV-2 virus. Genomic surveillance focuses on virus variants that cause severe illness and lead to hospitalization, as well as virus variants that could impact clinical care or vaccine efficacy, and samples from the Sentinella reporting system. The surveillance program comprises a network of laboratories coordinated by CRIVE. The subsidy covers the coordination of the surveillance program, the sequencing of the viral genome, and the analysis and publication of the resulting data.